LARIMAR THERAPEUTICS ANNOUNCES REGULATORY UPDATE CALL ON THE NOMLABOFUSP PROGRAM FOR THE TREATMENT OF FRIEDREICH’S ATAXIA

Reuters · 06/20 20:05

Please log in to view news